Lifecore Biomedical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Lifecore Biomedical stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 42.60% from the current stock price of 5.61.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$6.00	$8.00	$10	$10
Change	+6.95%	+42.60%	+78.25%	+78.25%

* Price targets were last updated on Jan 3, 2025.

Analyst Ratings

The average analyst rating for Lifecore Biomedical stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jacob Johnson Stephens & Co.	Stephens & Co.	Hold Reiterates $6	Hold	Reiterates	$6	+6.95%	Jan 3, 2025
Matthew Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $8 → $10	Strong Buy	Maintains	$8 → $10	+78.25%	Nov 22, 2024
Matthew Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+42.60%	Sep 5, 2024
Michael Petusky Barrington Research	Barrington Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Aug 28, 2024
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $11 → $10	Buy	Maintains	$11 → $10	+78.25%	Sep 1, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

131.13M

from 128.26M

2.24%

from 128.26M

Revenue Next Year

141.46M

from 131.13M

7.88%

from 131.13M

EPS This Year

-0.86

from 0.32

EPS Next Year

-0.61

from -0.86

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	May 31, 2020	May 30, 2021	May 29, 2022	May 28, 2023	May 26, 2024	May 26, 2025	May 26, 2026	May 26, 2027
Revenue	160.07M	100.87M	111.27M	103.27M	128.26M	131.13M	141.46M	157.70M
Revenue Growth	-71.29%	-36.98%	10.31%	-7.19%	24.20%	2.24%	7.88%	11.48%
EPS	-1.31	-1.10	-3.97	-3.32	0.32	-0.86	-0.61	-0.43
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	136.4M	149.4M	165.1M
Avg	131.1M	141.5M	157.7M
Low	124.5M	130.8M	147.2M

Revenue Growth

Revenue Growth	2025	2026	2027
High	6.3%	13.9%	16.7%
Avg	2.2%	7.9%	11.5%
Low	-2.9%	-0.2%	4.0%

EPS Forecast

EPS	2025	2026	2027
High	-0.88	-0.63	-0.42
Avg	-0.86	-0.61	-0.43
Low	-0.82	-0.59	-0.44

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.